Wapnick Pamela sold MGX
September 5, 2025 · Form 4 insider transaction
Wapnick Pamela sold 1,576 shares of Metagenomi Therapeutics, Inc. at $1.81 per share, a transaction worth $2.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 87 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,576
Price
$1.81
Total value
$2.9K
InsiderWapnick Pamela
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 5, 2025
Filing dateDecember 1, 2025
Shares owned after70,532
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units ("RSUs") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.